Association Between Cytometric Biomarkers, Clinical Phenotype, and Complications of Common Variable Immunodeficiency.

b cell phenotypic profiling common variable immunodeficiency immune dysregulation marginal zone b cells transitional b cells

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jan 2024
Historique:
accepted: 20 01 2024
medline: 26 2 2024
pubmed: 26 2 2024
entrez: 26 2 2024
Statut: epublish

Résumé

Common variable immunodeficiency (CVID) is a heterogeneous group of immune disorders. The patients are classified according to the clinical manifestation with the infection-only phenotype (CVID We performed a retrospective clinical analysis of 64 CVID patients (34 males, 53.13%; mean age: 41.4 years; SD: ±21.4 years). We divided the patients into subgroups according to the clinical manifestation (CVID Two-thirds of patients in our cohort had symptoms resulting from immune dysregulation. Almost half of the patients had autoimmune complications. A higher proportion of marginal zone B cells was associated with autoimmune complications. A lower percentage of naïve B cells was connected to autoimmunity, whereas a lower proportion of transitional B cells was associated with rheumatic diseases and splenomegaly. Patients with lymphadenopathy had a higher percentage of double-negative T cells and a lower percentage of switched memory B cells. We performed molecular-genetic testing in 28% (n = 17) of patients and found a causal pathogenic variant in 23.5% (n = 4) of this group. Based on our results, there is an association between specific cytometric parameters, clinical phenotype, and complications of CVID. The use of the subpopulations of B cells can be helpful in the diagnosis of these specific clinical complications in CVID patients and could help to personalise the therapeutic approach.

Sections du résumé

BACKGROUND BACKGROUND
Common variable immunodeficiency (CVID) is a heterogeneous group of immune disorders. The patients are classified according to the clinical manifestation with the infection-only phenotype (CVID
METHODS METHODS
We performed a retrospective clinical analysis of 64 CVID patients (34 males, 53.13%; mean age: 41.4 years; SD: ±21.4 years). We divided the patients into subgroups according to the clinical manifestation (CVID
RESULTS RESULTS
Two-thirds of patients in our cohort had symptoms resulting from immune dysregulation. Almost half of the patients had autoimmune complications. A higher proportion of marginal zone B cells was associated with autoimmune complications. A lower percentage of naïve B cells was connected to autoimmunity, whereas a lower proportion of transitional B cells was associated with rheumatic diseases and splenomegaly. Patients with lymphadenopathy had a higher percentage of double-negative T cells and a lower percentage of switched memory B cells. We performed molecular-genetic testing in 28% (n = 17) of patients and found a causal pathogenic variant in 23.5% (n = 4) of this group.
CONCLUSION CONCLUSIONS
Based on our results, there is an association between specific cytometric parameters, clinical phenotype, and complications of CVID. The use of the subpopulations of B cells can be helpful in the diagnosis of these specific clinical complications in CVID patients and could help to personalise the therapeutic approach.

Identifiants

pubmed: 38406025
doi: 10.7759/cureus.52941
pmc: PMC10894026
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e52941

Informations de copyright

Copyright © 2024, Markocsy et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Adam Markocsy (A)

Department of Paediatrics, Martin University Hospital, Martin, SVK.

Anna Bobcakova (A)

Department of Pulmonology and Phthisiology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, SVK.

Otilia Petrovicova (O)

Department of Paediatrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, SVK.

Lenka Kapustova (L)

Department of Paediatrics, Martin University Hospital, Martin, SVK.

Eva Malicherova Jurkova (E)

Department of Paediatrics, Martin University Hospital, Martin, SVK.

Martina Schniederova (M)

Department of Clinical Immunology and Allergology, Martin University Hospital, Martin, SVK.

Jela Petriskova (J)

Department of Clinical Immunology and Allergology, Martin University Hospital, Martin, SVK.

Michal Cibulka (M)

Department of Clinical Immunology and Allergology, Martin University Hospital, Martin, SVK.

Michaela Hyblova (M)

Department of Medical Genetics, Medirex a.s., Bratislava, SVK.

Milos Jesenak (M)

Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, SVK.

Classifications MeSH